Cutia Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	208.84	385.67	473.12	465.87	203.13
Short-Term Investments	10.68	10.53	330.19	567.15	769.65
Trading Asset Securities	461.99	479.96	469.34	43.5	405.49
Cash & Short-Term Investments	681.52	876.16	1,273	1,077	1,378
Cash Growth	-34.41%	-31.16%	18.22%	-21.89%	-
Accounts Receivable	38.03	100.53	63.5	1.34	0.5
Other Receivables	1.42	4.22	13.47	2.78	0
Receivables	39.45	104.75	76.97	4.12	0.5
Inventory	63.24	74.69	45.31	20	1.8
Other Current Assets	38.33	31.53	21.38	44.8	21.15
Total Current Assets	822.53	1,087	1,416	1,145	1,402
Property, Plant & Equipment	208.02	220.93	226.01	229.01	50.79
Other Intangible Assets	8.41	8.9	7.81	0.6	0.22
Long-Term Accounts Receivable	7.9	8.61	9.97	11.27	4.03
Other Long-Term Assets	35.3	34.41	14.95	30.23	26.86
Total Assets	1,116	1,393	1,707	1,447	1,495
Accounts Payable	1.18	12.82	20.29	-	0.34
Accrued Expenses	22.75	32.96	34.84	17.88	12.19
Short-Term Debt	122.38	173.3	89.41	-	-
Current Portion of Long-Term Debt	73.88	40	40	-	-
Current Portion of Leases	12.56	12.38	11.37	8.83	3.72
Current Income Taxes Payable	2.19	6.57	1.34	0.96	0.63
Current Unearned Revenue	-	-	0.4	-	-
Other Current Liabilities	25.05	45.23	57.13	49.73	2.39
Total Current Liabilities	260.01	323.25	254.79	77.4	19.25
Long-Term Debt	35.64	50	60	2,570	2,243
Long-Term Leases	45.93	45.26	42.97	45.3	22.82
Long-Term Unearned Revenue	18.04	-	-	0.4	0.4
Total Liabilities	359.62	418.51	357.76	2,693	2,285
Common Stock	0.05	0.05	0.04	0.01	0.01
Additional Paid-In Capital	4,691	4,691	4,686	259.16	259.16
Retained Earnings	-3,623	-3,384	-2,950	-986.11	-430.28
Treasury Stock	-13.86	-13.86	-	-	-
Comprehensive Income & Other	-297.28	-318.41	-387.02	-519.37	-619.4
Shareholders' Equity	756.62	974.73	1,349	-1,246	-790.51
Total Liabilities & Equity	1,116	1,393	1,707	1,447	1,495
Total Debt	290.41	320.94	243.76	2,624	2,269
Net Cash (Debt)	391.11	555.22	1,029	-1,548	-891.19
Net Cash Growth	-49.54%	-46.04%	-	-	-
Net Cash Per Share	1.24	1.81	5.03	-19.33	-11.13
Filing Date Shares Outstanding	319.47	318.59	304.02	80.05	80.05
Total Common Shares Outstanding	319.47	318.59	304.02	80.05	80.05
Working Capital	562.52	763.87	1,162	1,068	1,382
Book Value Per Share	2.37	3.06	4.44	-15.57	-9.88
Tangible Book Value	748.21	965.84	1,341	-1,247	-790.73
Tangible Book Value Per Share	2.34	3.03	4.41	-15.58	-9.88
Machinery	-	89.89	74.31	52.9	19.38
Construction In Progress	-	3.11	2.48	7.23	0.03
Leasehold Improvements	-	156.31	148.69	136.38	13.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.